Evaluation of the Effectiveness of Ischemic Pre-conditioning on the Morbidity and Mortality of Open Surgery of Thoracoabdominal Aortic Aneurysms. (EPICATA)

September 14, 2023 updated by: University Hospital, Rouen

Patients having a planned open surgery of thoracoabdominal aortic aneurysms and enrolled in the study will be randomized the day of the surgery in 2 groups:

  • Arm 1 : Patients with aortic clamping with pre-conditioning
  • Arm 2 : Patients with aortic clamping without pre-conditioning Patients will be then followed, during 60 days after surgery.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

65

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Rouen, France, 76031
        • University Hospital, Rouen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Patient > 18 and <85 years old
  2. Patient having a planned surgery for a thoracoabdominal aortic aneurysm by direct approach,
  3. Patient with aortic aneurysm requiring supra-visceral aortic clamping and visceral artery reconstruction,
  4. Aortic aneurysmal patient with or without distal femoral circulatory assistance,
  5. Patient with aortic aneurysm of atheromatous or dissecting etiology,
  6. Woman of childbearing potential with effective contraception (estrogen-progestin or intrauterine device or tubal ligation), postmenopausal woman (≥ 12 months of amenorrhea not induced by therapy)
  7. Patient who read and understood the newsletter and signed the consent form
  8. Patient affiliated with a social security scheme

Exclusion Criteria:

  1. Patient with aortic aneurysms requiring supra-visceral aortic clamping but not requiring visceral artery reconstruction (supra-visceral aortic clamping for renal aortic juxtaposition aorta),
  2. Patient with thoraco abdominal aortic aneurysms requiring a circulatory arrest (aortic aneurysms affecting the descending thoracic aorta or the aortic arch)
  3. Patient requiring emergency aortic surgery
  4. Patient under treatment known as interfering with PCI (Nicorandil or oral antidiabetic agents),
  5. Pregnant or lactating woman (negative result of baseline blood test)
  6. Participation in another interventional study within 28 days before randomization or during this study
  7. Person deprived of liberty by an administrative or judicial decision or person subject to a legal measure for the protection of adults,
  8. Patient under the protection of justice, patient under guardianship or curatorship.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Arm 1
Patients with aortic clamping withpre-conditioning

PCI procedure: clamping of the supracellular thoracic aorta for 5 minutes followed by a 5-minutes de-clamping period.

PCI procedure is repeated twice.

No Intervention: Arm 2
Patients with aortic clamping without pre-conditioning

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
occurrence of a pulmonary complication
Time Frame: Before the 48 hours after the beginning surgery
Need for prolonged invasive ventilation
Before the 48 hours after the beginning surgery
occurrence of a kidney complication
Time Frame: During the 8 days after surgery
According to RIFLE criteria
During the 8 days after surgery
occurrence of a pulmonary complication
Time Frame: During the 8 days after surgery
Occurrence of a moderate or severe acute respiratory distress syndrome (Berlin definition)
During the 8 days after surgery
occurrence of a pulmonary complication
Time Frame: During the 48 hours after initial extubation
Need for a new ventilation (invasive or not)
During the 48 hours after initial extubation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pulmonary Morbidity
Time Frame: During the 21 days after surgery
Need of a new ventilation (invasive or not)
During the 21 days after surgery
Kidney Morbidity
Time Frame: During the 21 days after surgery
According to RIFLE criteria
During the 21 days after surgery
Cardiac Morbidity
Time Frame: During the 48 hours after surgery
Value of troponin
During the 48 hours after surgery
cell and tissue damage
Time Frame: During the 8 days after surgery
Value of D Lactate
During the 8 days after surgery
Death
Time Frame: During 60 days after surgery
During 60 days after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 29, 2019

Primary Completion (Actual)

July 11, 2023

Study Completion (Actual)

July 29, 2023

Study Registration Dates

First Submitted

October 23, 2018

First Submitted That Met QC Criteria

October 23, 2018

First Posted (Actual)

October 24, 2018

Study Record Updates

Last Update Posted (Actual)

September 18, 2023

Last Update Submitted That Met QC Criteria

September 14, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery

Clinical Trials on clamping with pre-conditioning (PCl)

3
Subscribe